Antisynthetase syndrome

Current Rheumatology Reports

Volumn 13, Issue 3, 2011, Pages 175-181

  Katzap, Elena ^a   Barilla Labarca, Maria Louise ^a   Marder, Galina ^a  

^a North Shore Long Island Jewish Health System ^*  (United States)

Author keywords

Antisynthetase autoantibodies; Antisynthetase syndrome; Arthritis; Autoantibodies; Corticosteroid; Cutaneous; Interstitial lung disease; Jo 1; Myositis; Pulmonary disease

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GLUCOCORTICOID; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TACROLIMUS;

ANTISYNTHETASE SYNDROME; ARTHROPATHY; ARTICLE; CLINICAL FEATURE; DERMATOMYOSITIS; DRUG EFFICACY; FEVER; HUMAN; HYPERKERATOSIS; INTERSTITIAL LUNG DISEASE; MORBIDITY; MORTALITY; MUSCLE DISEASE; MYOSITIS; PATHOGENESIS; POLYMYOSITIS; PROGNOSIS; RAYNAUD PHENOMENON; RHEUMATOID ARTHRITIS;

AMINO ACYL-TRNA SYNTHETASES; ANTIBODIES, ANTINUCLEAR; ARTHRITIS; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG; LUNG DISEASES, INTERSTITIAL; MYOSITIS;

EID: 79957510404     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-011-0176-8     Document Type: Article

References (57)

1. DP Ascherman 2003 The role of Jo-1 in the immunopathogenesis of polymyositis: current hypotheses Curr Rheumatol Rep 5 6 425 430 14609486 10.1007/s11926-003-0052-2
2. KB Stone CV Oddis N Fertig, et al. 2007 Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy Arthritis Rheum 56 9 3125 3131 17763431 10.1002/art.22865 1:CAS:528:DC%2BD2sXht1GgtbrP (Pubitemid 47502760)
3. IN Targoff 2008 Autoantibodies and their significance in myositis Curr Rheumatol Rep 10 4 333 340 18662515 10.1007/s11926-008-0053-2 1:CAS:528:DC%2BD1MXisVSmurc%3D
4. TJ Richards A Eggebeen K Gibson, et al. 2009 Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease Arthritis Rheum 60 7 2183 2192 19565490 10.1002/art.24631 1:CAS:528:DC%2BD1MXptlKrsb4%3D The authors address the prevalence of ILD in a large cohort of patients with anti-Jo-1 antibodies and describe various clinical characteristics of such patients. The authors also identify various chemokines that may help a clinician distinguish Jo-1-positive ILD patients from others with idiopathic pulmonary fibrosis or anti-signal recognition particle-related myositis
5. Marder GS, Greenwald R. Antisynthetase syndrome. In: Kagen LJ, editor. The inflammatory myopathies. Humana Press; 2009. p. 191-206.
6. A Fischer JJ Swigris RM du Bois, et al. 2009 Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia Respir Med 103 11 1719 1724 19497723 10.1016/j.rmed.2009.05.001
7. M Kalluri SA Sahn CV Oddis, et al. 2009 Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature Chest 135 6 1550 1556 19225060 10.1378/chest.08-2233 1:CAS:528:DC%2BD1MXot12qsrs%3D
8. M Hirakata A Suwa S Nagai, et al. 1999 Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease J Immunol 162 4 2315 2320 9973509 1:CAS:528: DyaK1MXhtVOlu74%3D (Pubitemid 29288856)
9. Z Betteride H Gunawardena J North, et al. 2007 Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia Rheumatology (Oxford) 46 6 1005 1008 10.1093/rheumatology/kem045 (Pubitemid 47062512)
10. L Hashish EP Trieu P Sadanandan, et al. 2005 Identification of autoantibodies to tyrosyl-tRNA synthetase in dermatomyositis with features consistent with antisynthetase syndrome Arthritis Rheum 52 Suppl. 9 S312
11. M Nishikai M Reichlin 1980 Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system Arthritis Rheum 23 8 881 888 7406938 10.1002/art.1780230802 1:STN:280: DyaL3c3msFehtw%3D%3D (Pubitemid 10040117)
12. IN Targoff 2002 Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies Rheum Dis Clin North Am 28 4 859 890 12506776 10.1016/S0889-857X(02)00032-7 (Pubitemid 36008556)
13. R Brouwer GJD Hengstman WV Egberts, et al. 2001 Autoantibody profiles in the sera of European patients with myositis Ann Rheum Dis 60 2 116 123 11156543 10.1136/ard.60.2.116 1:STN:280:DC%2BD3M7is1SqsA%3D%3D (Pubitemid 32102201)
14. A Selva-O'Callaghan M Labrador-Horrillo R Solans-Laque, et al. 2006 Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy Arthritis Rheum 55 5 791 798 17013837 10.1002/art.22237 (Pubitemid 44619194)
15. IN Targoff 2000 Update on myositis-specific and myositis-associated autoantibodies Curr Opin Rheumatol 12 6 475 481 11092195 10.1097/00002281- 200011000-00001 1:CAS:528:DC%2BD3cXosVejsb0%3D
16. OM Howard HF Dong D Yang, et al. 2002 Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells J Exp Med 196 6 781 791 12235211 10.1084/jem.20020186 1:CAS:528:DC%2BD38Xnt1yhtL4%3D
17. SG Park HJ Kim YH Min, et al. 2005 Human lysyl-tRNA synthetase is secreted to trigger proinflammatory response Proc Natl Acad Sci USA 102 18 6356 6361 15851690 10.1073/pnas.0500226102 1:CAS:528:DC%2BD2MXktlygtro%3D (Pubitemid 40617447)
18. M Soejima EH Kang X Gu, et al. 2011 Role of innate immunity in a model of histidyl-tRNA synthetase (Jo-1)-mediated myositis Arthritis Rheum 63 2 479 487 21280002 10.1002/art.30113 1:CAS:528:DC%2BC3MXivVOksrk%3D
19. FW Miller KA Waite T Biswas, et al. 1990 The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity Proc Natl Acad Sci USA 87 24 9933 9937 1702223 10.1073/pnas.87.24.9933 1:CAS:528:DyaK3MXktVyguw%3D%3D (Pubitemid 120016558)
20. K Nagaraju N Raben L Loeffler, et al. 2000 Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies Proc Natl Acad Sci USA 97 16 9209 9214 10922072 10.1073/pnas.97.16.9209 1:CAS:528:DC%2BD3cXls12ksLY%3D (Pubitemid 30626699)
21. Y Katsumata WM Ridgway T Oriss, et al. 2007 Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation J Autoimmun 29 2-3 174 186 17826948 10.1016/j.jaut.2007.07.005 1:CAS:528:DC%2BD2sXhtVCmur3K (Pubitemid 47393612)
22. S Barbasso Helmers P Englund M Engström, et al. 2009 Sera from anti-Jo-1-positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cells Arthritis Rheum 60 8 2524 2530 19644880 10.1002/art.24683
23. DP Ascherman TB Oriss CV Oddis, et al. 2002 Critical requirement for professional APCs in eliciting T cell responses to novel fragments of histidyl-tRNA synthetase (Jo-1) in Jo-1 antibody-positive polymyositis J Immunol 169 12 7127 7134 12471150 1:CAS:528:DC%2BD38XpsFGjtro%3D (Pubitemid 36899302)
24. SM Levine N Raben D Xie, et al. 2007 Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis Arthritis Rheum 56 8 2729 2739 17665459 10.1002/art.22790 1:CAS:528:DC%2BD2sXhtVWqu7fM (Pubitemid 47237292)
25. T Mozaffar A Pestronk 2000 Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres J Neurol Neurosurg Psychiatry 68 4 472 478 10727483 10.1136/jnnp.68.4.472 1:STN:280:DC%2BD3c7ptlOhsg%3D%3D (Pubitemid 30248747)
26. H Yoshifuji T Fujii S Kobayashi, et al. 2006 Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies Autoimmunity 39 3 233 241 16769657 10.1080/08916930600622884 1:CAS:528:DC%2BD28XnsFGltb0%3D (Pubitemid 43879036)
27. WA Schmidt W Wetzel R Friedländer, et al. 2000 Clinical and serological aspects of patients with anti-Jo-1 antibodies-an evolving spectrum of disease manifestations Clin Rheumatol 19 5 371 377 11055826 10.1007/s100670070030 1:STN:280:DC%2BD3crgsFWntw%3D%3D
28. IN Targoff EP Trieu FW Miller 1993 Reaction of anti-OJ autoantobodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase J Clin Invest 9 2556 2564 10.1172/JCI116493 (Pubitemid 23182509)
29. S Mii R Kobayashi T Nakano, et al. 2009 A histopathologic study of mechanic's hands associated with dermatomyositis: a report of five cases Int J Dermatol 48 11 1177 1182 20064170 10.1111/j.1365-4632.2009.04164.x
30. C Bachmeyer I Tillie-Leblond A Lacert, et al. 2007 "Mechanic's hands": a misleading cutaneous sign of the antisynthetase syndrome Br J Dermatol 156 1 192 194 17199601 10.1111/j.1365-2133.2006.07593.x 1:STN:280:DC%2BD2s%2FgsVSjtA%3D%3D (Pubitemid 44924178)
31. P Mielnik E Wiesik-Szewczyk M Olesinska, et al. 2006 Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies Autoimmunity 39 3 243 247 16769658 10.1080/08916930600623767 1:CAS:528:DC%2BD28XnsFGltbo%3D (Pubitemid 43879037)
32. O Meyer H Charlanne P Cherin, et al. 2009 Subluxing arthropathy: an unusual manifestation of the antisynthetase syndrome Ann Rheum Dis 68 1 152 153 19088260 10.1136/ard.2007.078907 1:STN:280:DC%2BD1M%2Fjs1Cgtg%3D%3D
33. CV Oddis TA Medsger Jr LA Cooperstein 1990 A subluxing arthropathy associated with the anti-Jo-1 antibody in polymyositis/dermatomyositis Arthritis Rheum 33 11 1640 1645 2242062 10.1002/art.1780331106 1:STN:280: DyaK3M%2FlsVKnsA%3D%3D
34. GE Mumm KM McKown, et al. 2010 Antisynthetase syndrome presenting as rheumatoid-like polyarthritis J Clin Rheumatol 16 7 307 312 20859229
35. AS Morgenthau ML Padilla 2009 Spectrum of fibrosing diffuse parenchymal lung disease Mt Sinai J Med 76 1 2 23 19170214 10.1002/msj.20087
36. K Takada K Nagasaka N Miyasaka 2005 Polymyositis/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants Autoimmunity 38 5 383 392 16227154 10.1080/08916930500124023 1:CAS:528:DC%2BD2MXhtFWhtLbK (Pubitemid 41358669)
37. A Váncsa I Csípo J Németh, et al. 2009 Characteristics of interstitial lung disease in SS-A positive/Jo-1 positive inflammatory myopathy patients Rheumatol Int 29 9 989 994 19266202 10.1007/s00296-009-0884-9 Epub 2009 Mar 6
38. AW Friedman IN Targoff FC Arnett 1996 Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis Semin Arthritis Rheum 26 1 459 467 8870113 10.1016/S0049-0172(96)80026-6 1:CAS:528:DyaK28XlvVWisLs%3D (Pubitemid 26274719)
39. I Tillie-Leblond M Wislez D Valeyre, et al. 2008 Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset Thorax 63 1 53 59 17557770 10.1136/thx.2006.069237 1:STN:280: DC%2BD2sjlvFynsA%3D%3D
40. S Guglielmi TM Merz M Gugger, et al. 2008 Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus Eur Respir J 31 1 213 217 18166599 10.1183/09031936.00014707 1:CAS:528: DC%2BD1cXhvVCgsLo%3D
41. A Schnabel M Reuter J Biederer, et al. 2003 Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment Semin Arthritis Rheum 32 5 273 284 12701038 10.1053/sarh.2002.50012 (Pubitemid 36459277)
42. SY Ji FQ Zeng Q Guo, et al. 2010 Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study Chin Med J (Engl) 123 5 517 522 1:CAS:528:DC%2BC3cXksl2mu78%3D This article would help readers recognize some of the adverse prognostic factors that may be present in patients with ILD and inflammatory myopathy at the time of diagnosis, and in turn recognize the need for early intervention and more aggressive therapy when indicated
43. WW Douglas HD Tazelaar TE Hartman, et al. 2001 Polymyositis- dermatomyositis-associated interstitial lung disease Am J Respir Crit Care Med 164 7 1182 1185 11673206 1:STN:280:DC%2BD3Mrms1OhtQ%3D%3D (Pubitemid 33052247)
44. R La Corte A Lo Mo Naco A Locaputo, et al. 2006 In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease Autoimmunity 39 3 249 253 16769659 10.1080/08916930600623791 (Pubitemid 43879038)
45. Cassidy EA, Aggarwal R, Fertig N, et al. Non-Jo-1 Anti-synthetase autoantibodies are not specific for myositis and are associated with poor survival. Arthritis & Rheumatism Abstract Supplement 2010. Abstract 929.
46. M Kubo H Ihn K Yamane, et al. 2000 Serum KL-6 in adult patients with polymyositis and dermatomyositis Rheumatology (Oxford) 39 6 632 636 10.1093/rheumatology/39.6.632 1:CAS:528:DC%2BD3cXlvVektbw%3D (Pubitemid 30459949)
47. Barbasso Helmers S, Maryam Fathi M, Lundber IE, et al. KL-6: A serological biomarker for interstitial lung disease and pulmonary function in patients with polymyositis and dermatomyositis. Arthritis & Rheumatism Abstract Supplement 2010. Abstract 924.
48. S Chatterjee C Farver 2010 Severe pulmonary hypertension in Anti-Jo-1 syndrome Arthritis Care Res (Hoboken) 62 3 425 429 10.1002/acr.20109
49. T Handa S Nagai D Kawabata, et al. 2005 Long-term clinical course of a patient with anti PL-12 antibody accompanied by interstitial pneumonia and severe pulmonary hypertension Intern Med 44 4 319 325 15897644 10.2169/internalmedicine.44.319 (Pubitemid 40663035)
50. Fathi M. Interstitial lung disease in polymyositis and dermatomyositis. Stockholm: Karolinska Institutet; 2006.
51. KA Knoell M Hook DP Grice, et al. 1999 Dermatomyositis associated with bronchiolitis obliterans organizing pneumonia (BOOP) J Am Acad Dermatol 40 2 Pt 2 328 330 10025861 10.1016/S0190-9622(99)70478-0 1:STN:280:DyaK1M7kvVOhug%3D%3D (Pubitemid 29076092)
52. B Hervier A Masseau JM Mussini, et al. 2009 Long-term efficacy of mycophenolate mofetil in a case of refractory antisynthetase syndrome Joint Bone Spine 76 5 575 576 19464224 10.1016/j.jbspin.2009.02.004
53. M Jankowska B Butto A Debska-Slizień, et al. 2007 Beneficial effect of treatment with cyclosporin A in a case of refractory antisynthetase syndrome Rheumatol Int 27 8 775 780 17221173 10.1007/s00296-006-0289-y (Pubitemid 46716722)
54. MR Wilkes SM Sereika N Fertig, et al. 2005 Treatment of antisynthetase-associated interstitial lung disease with tacrolimus Arthritis Rheum 52 8 2439 2446 16052580 10.1002/art.21240 1:CAS:528:DC%2BD2MXpslGht7w%3D (Pubitemid 41117430)
55. Y Suzuki H Hayakawa S Miwa, et al. 2009 Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/dermatomyositis Lung 187 3 201 206 19387736 10.1007/s00408-009- 9146-6 1:CAS:528:DC%2BD1MXlvFyisL0%3D
56. E Vandenbroucke JC Grutters J Altenburg, et al. 2009 Rituximab in life threatening antisynthetase syndrome Rheumatol Int 29 12 1499 1502 19184665 10.1007/s00296-009-0859-x 1:CAS:528:DC%2BD1MXhtVWiurrK
57. L Brulhart JM Waldburger C Gabay 2006 Rituximab in the treatment of antisynthetase syndrome Ann Rheum Dis 65 7 974 975 16769789 10.1136/ard.2005. 045898 1:STN:280:DC%2BD28zlsVKntg%3D%3D